Literature DB >> 2899236

Effects of intermittent treatment with aspirin on thromboxane and prostacyclin formation in patients with acute myocardial infarction.

G Rasmanis1, O Vesterqvist, K Gréen, O Edhag, P Henriksson.   

Abstract

Thromboxane and prostacyclin formation were monitored in twenty patients with acute myocardial infarction. Ten received 500 mg acetylsalicylic acid (ASA) orally starting 12 h after admission and then intermittently every third day for one month; the other ten did not receive ASA or any other drug known to interfere with the synthesis of prostanoids. In the ASA group thromboxane formation, initially raised, fell rapidly and remained low. In the control group thromboxane formation decreased very slowly and was not normal by the end of the study period. Prostacyclin formation seemed identical in the two groups. Thus intermittent ASA, in this dosage, efficiently inhibited the enhanced thromboxane formation in acute myocardial infarction without interfering with prostacyclin formation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899236     DOI: 10.1016/s0140-6736(88)92537-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

Review 1.  North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-04-25

2.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

3.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

4.  Evidence of increased platelet activation after thrombolysis in patients with acute myocardial infarction.

Authors:  G Rasmanis; O Vesterqvist; K Gréen; O Edhag; P Henriksson
Journal:  Br Heart J       Date:  1992-10

5.  Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels.

Authors:  Catharina Borna; Eduardo Lazarowski; Catharina van Heusden; Hans Ohlin; David Erlinge
Journal:  Thromb J       Date:  2005-07-26

6.  The effectiveness of low dose slow release aspirin as an antiplatelet agent.

Authors:  J S Budd; K Allen; A Walsh; P R Bell
Journal:  J R Soc Med       Date:  1993-05       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.